Emma began her career in basic science research before pursuing a medical degree and specialising in infectious diseases. Throughout her training, she remained committed to research, contributing to multiple projects that deepened her understanding of disease mechanisms and patient care. This foundation in both science and medicine shaped her approach to clinical practice, particularly during the COVID-19 pandemic.
Immersed in all aspects of COVID-19 care, Emma played a key role in establishing ambulatory care networks for acute COVID-19 in Victoria and provided medical support for healthcare staff experiencing post-COVID syndrome (long COVID).
Recognising the lack of dedicated services for people with long COVID, she founded Clinic Nineteen, a pioneering private clinic designed to address the ongoing needs of patients. The clinic continues to grow, expanding its services to include paediatric care and providing care to people with Long COVID across Australia.
Driven by a genuine commitment to finding effective treatments—and ultimately a cure for long COVID, Emma has returned to research at Burnet Institute. As a co-lead in developing an adaptive platform long COVID clinical trial, she is spearheading efforts to identify effective therapies, better understand the pathobiology of the disease, and explore novel treatment options. Her work bridges clinical care and research, with the goal of improving outcomes for people living with long COVID.
Internal Medicine Journal
Michelle J. L. Scoullar, Emma Tippett
The Medical Journal of Australia
Michelle J. L. Scoullar, Gabriela Khoury, S. S. Majumdar, Emma Tippett, Brendan S. Crabb
Journal of Leukocyte Biology
Emma Tippett, Paul Cameron, Suzanne M. Crowe
HEAL APT: Harnessing effective approaches for long COVID therapies through an adaptive platform trial.
A whole of institute initiative that brings together Burnet’s multi-disciplinary skills to tackle the complex challenges of pandemics and health emergencies caused by infectious diseases.